1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Regenera Pharma Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease RPh201, botanical drug product, Placebo - Healthy Volunteers, Moderate to Severe Alzheimer Patients | Phase 1 / Phase 2 | Completed | Regenera Pharma Ltd | 39 | 2012-01-01 | 2020-03-23 |
| Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn RPh201, botanical drug product - Second Degree Burn Less Than 5%TBSA, Partial Thickness Burn | Phase 1 / Phase 2 | Withdrawn | Regenera Pharma Ltd | 2011-12-01 | 2016-12-06 | |
| Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds RPh201, botanical drug product - Chronic Wound | Phase 1 / Phase 2 | Terminated | Regenera Pharma Ltd | 4 | 2011-12-01 | 2018-09-04 |
Dementia (1) · Venous Insufficiency (1)
Israel (2) · Canada (1)
Eran Tamir, Dr. (1) · Eyal Winkler, Dr. MD (1) · Janice Faulknor, MD (1) · Sharon Cohen, MD (1)